Ligia Carolina Facin: Investigating a Novel Therapeutic Strategy for ATTR-CM
Ligia Carolina Facin, Fellowship in Cardiac Amyloidosis at Ensino InCor, Cardio-Oncology Resident at Heart Institute, University of São Paulo (FMUSP), shared a post on LinkedIn:
“It was a great privilege to participate in the CLEOPATTRA Investigators’ Meeting, an international clinical trial investigating a novel therapeutic strategy for transthyretin amyloid cardiomyopathy (ATTR-CM).
Over the past few years, we have witnessed remarkable advances in the treatment of ATTR-CM.
Now, a new frontier is being explored: therapies aimed at removing amyloid deposits already present in cardiac tissue, with the potential to further transform the course of the disease.
Being part of a study investigating this innovative therapeutic approach is a unique opportunity to contribute to the evidence that may shape the future of cardiac amyloidosis treatment.
Science, international collaboration, and clinical research opening new perspectives for our patients.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series